Bone Biologics Corporation (BBLGW) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bone Biologics Corporatio...

    NASDAQ: BBLGW · Real-Time Price · USD
    10.79
    0.00 (0.00%)
    At close: Sep 03, 2025, 3:10 PM

    Bone Biologics Revenue

    Bone Biologics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Bone Biologics generated $0 in revenue.
    Revenue (ttm)
    0
    Revenue Growth
    n/a
    Price / Sales Ratio
    0
    Revenue / Employee
    0
    Employees
    2
    Market Cap
    3.76M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Dec 31, 2023 0 n/a
    Dec 31, 2022 0 n/a
    Dec 31, 2021 0 n/a
    Dec 31, 2020 0 n/a
    Dec 31, 2019 0 n/a
    Dec 31, 2018 0 n/a
    Dec 31, 2017 0 n/a
    Dec 31, 2016 0 n/a
    Dec 31, 2015 0 n/a
    Dec 31, 2014 0 n/a
    Oct 31, 2013 0 n/a
    Oct 31, 2012 0 n/a
    Oct 31, 2011 0 n/a
    Oct 31, 2010 0 n/a
    Oct 31, 2009 0 n/a
    Oct 31, 2008 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist